Monash Health

Futó vizsgálatok

• Még nem toboroz

  Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR

  NCT07696182· Abbott Medical Devices· Forrás

• Még nem toboroz

  NTI164 in Autism Spectrum Disorder

  NCT07257939· 3. fázis· Fenix Innovation Group· Forrás

• Toboroz

  Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy

  NCT07640191· iVEAcare· Forrás

• Toboroz

  A Study of ARC-02 in B-cell NHL

  NCT07691606· 1. fázis· Taiho Oncology, Inc.· Forrás

• Toboroz

  A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

  NCT07470879· 2. fázis· Pfizer· Forrás

• Toboroz

  RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

  NCT07413939· 2/3. fázis· Hoffmann-La Roche· Forrás

• Még nem toboroz

  Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)

  NCT07527819· Peter MacCallum Cancer Centre, Australia· Forrás

• Toboroz

  A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

  NCT07221149· 2/3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

  NCT07421700· 1/2. fázis· Pfizer· Forrás

• Toboroz

  A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  NCT07363694· 2/3. fázis· Pfizer· Forrás

• Toboroz

  Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

  NCT07227415· 1/2. fázis· Pfizer· Forrás

• Toboroz

  A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

  NCT07277231· 3. fázis· BeOne Medicines· Forrás

• Toboroz

  A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.

  NCT07235293· 2. fázis· Kahr Bio Australia Pty Ltd· Forrás

• Toboroz

  Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  NCT07222800· 3. fázis· Pfizer· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

  NCT07174310· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease

  NCT07246941· 1. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

  NCT07186842· 1/2. fázis· BioNTech SE· Forrás

• Fut, nem toboroz

  A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

  NCT07036523· 2. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma

  NCT07245368· 1/2. fázis· Prana Therapies Inc· Forrás

• Még nem toboroz

  An Extension Study to Assess the Long-term Safety of the Genio® System

  NCT05939141· Nyxoah S.A.· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  NCT06793215· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

  NCT07196722· 2/3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07196748· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study to Evaluate Adze1.C in Participants With Metastatic Melanoma

  NCT07086105· 1. fázis· Adze Biotechnology Australia Pty Ltd· Forrás

• Toboroz

  Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study

  NCT07055542· University of Melbourne· Forrás

• Toboroz

  Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

  NCT06982521· 3. fázis· Relay Therapeutics, Inc.· Forrás

• Toboroz

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

  NCT06943755· 2/3. fázis· Exelixis· Forrás

• Toboroz

  A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

  NCT06943872· 3. fázis· BeOne Medicines· Forrás

• Fut, nem toboroz

  ASCEND CSP IDE Study

  NCT06830746· Abbott Medical Devices· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

  NCT06790693· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

  NCT06742996· 3. fázis· BeOne Medicines· Forrás

• Fut, nem toboroz

  Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer

  NCT05093231· 2. fázis· Cambridge University Hospitals NHS Foundation Trust· Forrás

• Fut, nem toboroz

  Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01

  NCT06727565· 2. fázis· Gilead Sciences· Forrás

• Fut, nem toboroz

  A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

  NCT06679985· 2. fázis· Coherus Oncology, Inc.· Forrás

• Toboroz

  Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

  NCT06465953· 3. fázis· Institut de Recherches Internationales Servier· Forrás

• Toboroz

  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  NCT06632457· 3. fázis· Boehringer Ingelheim· Forrás

• Fut, nem toboroz

  A Study of DM001 in Patients With Advanced Solid Tumors

  NCT06475937· 1. fázis· Xadcera Biopharmaceutical (Suzhou) Co., Ltd.· Forrás

• Fut, nem toboroz

  A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

  NCT06551324· 3. fázis· Pfizer· Forrás

• Toboroz

  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  NCT06632444· 3. fázis· Boehringer Ingelheim· Forrás

• Fut, nem toboroz

  To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

  NCT06553027· 3. fázis· Cerevance· Forrás

• Toboroz

  Respiratory Sinus Arrhythmia Pacing Post-CABG Surgery in Patients With HFrEF

  NCT06384963· Ceryx Medical Australia· Forrás

• Fut, nem toboroz

  Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

  NCT06564142· 3. fázis· Alpine Immune Sciences Inc, A Subsidiary of Vertex· Forrás

• Fut, nem toboroz

  Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

  NCT06486441· 3. fázis· Gilead Sciences· Forrás

• Toboroz

  Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

  NCT06500273· 2. fázis· Allogene Therapeutics· Forrás

• Toboroz

  A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS

  NCT06372717· 1. fázis· Apollo Therapeutics Ltd· Forrás

• Fut, nem toboroz

  Evaluating Efficacy and Safety of CBD TPM Capsules for Use in Insomnia

  NCT05840822· 3. fázis· Avecho Biotechnology· Forrás

• Meghívásos bevonás

  ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation

  NCT05932615· Abbott Medical Devices· Forrás

• Fut, nem toboroz

  A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

  NCT06257264· 1. fázis· BeiGene· Forrás

• Toboroz

  Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

  NCT06162221· 1/2. fázis· Revolution Medicines, Inc.· Forrás

Showing 50 of 91.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Aortic stenosis3 toboroz
• Áttétes emlőrák3 toboroz
• Hólyagrák3 toboroz
• Mielodiszplasztikus szindróma (MDS)3 toboroz
• Petefészekrák3 toboroz
• Tüdőrák3 toboroz
• Vastagbélrák3 toboroz
• Akut mieloid leukémia (AML)2 toboroz
• Asztma2 toboroz
• Colitis ulcerosa2 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)2 toboroz
• Follikuláris limfóma2 toboroz
• Gyomor- és nyelőcsőrák2 toboroz
• Hasnyálmirigyrák2 toboroz
• Krónikus limfoid leukémia (CLL)2 toboroz
• Melanóma2 toboroz
• Parkinson-kór2 toboroz
• Szívelégtelenség2 toboroz
• Vesedaganat2 toboroz
• Zsírmáj (MASLD/MASH)2 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Autizmus spektrumzavar1 toboroz
• Crohn-betegség1 toboroz
• Epilepszia1 toboroz
• Familiáris hiperkoleszterinémia1 toboroz
• Fej-nyaki daganatok1 toboroz
• Hodgkin-limfóma1 toboroz
• Köpenysejtes limfóma1 toboroz
• Koszorúér-betegség1 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)1 toboroz
• Liver cirrhosis1 toboroz
• Magas vérnyomás1 toboroz
• Máj- és epeúti rák1 toboroz
• Méhtestrák1 toboroz
• Mezotelióma1 toboroz
• Mielóma multiplex1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Neuroendokrin daganatok1 toboroz
• Obstructive sleep apnoea1 toboroz
• Pikkelysömör1 toboroz
• Stroke (szélütés)1 toboroz
• Tripla negatív emlőrák1 toboroz

Lezárt vizsgálatok

• Leállították

  A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification

  NCT06585488· 1. fázis· BeOne Medicines· Forrás

• Lezárult

  VOLT-AF IDE Clinical Study

  NCT06223789· Abbott Medical Devices· Forrás

• Lezárult

  A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old

  NCT06064929· 1. fázis· HI-Bio, A Biogen Company· Forrás

• Lezárult

  A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies

  NCT05665530· 1. fázis· Prelude Therapeutics Incorporated· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

  NCT05894239· 3. fázis· Hoffmann-La Roche· Forrás

• Leállították

  The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only

  NCT04876651· 3. fázis· Telix Pharmaceuticals (Innovations) Pty Ltd· Forrás

• Leállították

  A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies

  NCT05828589· 1. fázis· BeOne Medicines· Forrás

• Lezárult

  A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer

  NCT05775289· 2. fázis· Hoffmann-La Roche· Forrás

• Leállították

  Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder

  NCT05555615· 2/3. fázis· ACADIA Pharmaceuticals Inc.· Forrás

• Lezárult

  Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder

  NCT05523895· 2/3. fázis· ACADIA Pharmaceuticals Inc.· Forrás

• Lezárult

  A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)

  NCT05358717· 2. fázis· Novartis Pharmaceuticals· Forrás

• Leállították

  The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

  NCT04985968· 3. fázis· InDex Pharmaceuticals· Forrás

• Lezárult

  Study of WVE-003 in Patients With Huntington's Disease

  NCT05032196· 1/2. fázis· Wave Life Sciences USA, Inc.· Forrás

• Leállították

  Tislelizumab in Combination With Sitravatinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  NCT04921358· 3. fázis· BeiGene· Forrás

• Lezárult

  RegoNivo vs Standard of Care Chemotherapy in AGOC

  NCT04879368· 3. fázis· Australasian Gastro-Intestinal Trials Group· Forrás

• Lezárult

  DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma

  NCT04334759· 3. fázis· PrECOG, LLC.· Forrás

• Lezárult

  A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer

  NCT04322539· 3. fázis· Hutchison Medipharma Limited· Forrás

• Lezárult

  Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab

  NCT04282018· 1/2. fázis· BeiGene· Forrás

• Lezárult

  Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors

  NCT04215978· 1. fázis· BeiGene· Forrás

• Lezárult

  A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression

  NCT04209855· 3. fázis· AbbVie· Forrás

• Leállították

  A Study of Imvotamab Monotherapy and in Combination in Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma

  NCT04082936· 1/2. fázis· IGM Biosciences, Inc.· Forrás

• Lezárult

  A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases

  NCT03497767· 2. fázis· Trans Tasman Radiation Oncology Group· Forrás

• Lezárult

  Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation

  NCT03795298· Boston Scientific Corporation· Forrás

• Lezárult

  A Trial of Radiotherapy and Durvalumab in DLBCL and FL

  NCT03610061· 1. fázis· Austin Health· Forrás

• Lezárult

  A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia

  NCT03734016· 3. fázis· BeiGene· Forrás

• Leállították

  WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2

  NCT03302494· 3. fázis· Coherex Medical· Forrás

• Lezárult

  A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma

  NCT03332017· 2. fázis· BeiGene· Forrás

• Lezárult

  A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers

  NCT02923934· 2. fázis· Olivia Newton-John Cancer Research Institute· Forrás

• Lezárult

  Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease

  NCT03020303· 3. fázis· Hamilton Health Sciences Corporation· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Koszorúér-betegség30 munka · 2 vizsgálat
• Lupus (SLE)28 munka · 1 vizsgálat
• Csontritkulás26 munka · 0 vizsgálat
• Polycystic ovary syndrome19 munka · 0 vizsgálat
• Szisztémás szklerózis (szkleroderma)13 munka · 0 vizsgálat
• Brain aneurysm11 munka · 0 vizsgálat
• Hodgkin-limfóma11 munka · 2 vizsgálat
• Cerebral palsy9 munka · 0 vizsgálat
• Mielodiszplasztikus szindróma (MDS)8 munka · 4 vizsgálat